Atlas Trials

Efficacy and Safety Evaluating Fispemifene in the Treatment of Hypogonadal Men With Erectile Dysfunction Unresponsive to PDE5 Inhibitors

Clinical trial NCT00415571 · COMPLETED

Trial details

NCT number
NCT00415571
Sponsor
QuatRx Pharmaceuticals Company
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
HypogonadismErectile Dysfunction
Start date
2006-12-01
Enrollment
72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.